Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
8,8 USD | +0,80% | +4,02% | +6,93% |
10/07 | Barclays alza Kerry, taglia Hunting, Gruppo Wood | AN |
10/07 | Borsa di Italia: Mercati collegati alla corrente alternata |
Attività
- prodotti per la salute orale (27,7%; n. 1 a livello mondiale): Sensodyne, Parodontax, Polident, Biotene, Aquafresh, ecc;
- farmaci antidolorifici (23,5%; n. 1 a livello mondiale): Panadol, Advil, Voltaren, Excedrin, ecc;
- farmaci per la salute dell'apparato digerente (18,9%; n. 1 nel mondo): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium, ecc;
- farmaci per le vie respiratorie (15,4%; n. 1 nel mondo): Theraflu, Otrivin, Flonase, Contac, ecc;
- vitamine, minerali e integratori alimentari (14,5%; n. 1 a livello mondiale): I marchi Centrum, Emergen-C, Caltrate, ecc.
Le vendite nette sono distribuite geograficamente come segue: Europa/Medio Oriente/Africa/America Latina (40,2%), Nord America (37,1%) e Asia/Pacifico (22,7%).
Numero di dipendenti: 25 408
Vendite per attività
GBP in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Oral Health
27,7
%
| 2 957 | 27,2 % | 3 136 | 27,7 % | +6,05% |
Pain Relief
23,5
%
| 2 551 | 23,5 % | 2 652 | 23,5 % | +3,96% |
Digestive Health and Other
18,9
%
| 2 096 | 19,3 % | 2 138 | 18,9 % | +2,00% |
Respiratory Health
15,4
%
| 1 579 | 14,5 % | 1 736 | 15,4 % | +9,94% |
Vitamins, Minerals and Supplements
14,5
%
| 1 675 | 15,4 % | 1 640 | 14,5 % | -2,09% |
Vendite per regione
GBP in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
EMEA and Latin America
40,2
%
| 4 270 | 39,3 % | 4 545 | 40,2 % | +6,44% |
North America
37,1
%
| 4 116 | 37,9 % | 4 195 | 37,1 % | +1,92% |
APAC
22,7
%
| 2 472 | 22,8 % | 2 562 | 22,7 % | +3,64% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Brian McNamara
CEO | Chief Executive Officer | 57 | 22/07/21 |
Tobias Hestler
DFI | Director of Finance/CFO | 52 | 01/12/21 |
Franck Riot
CTO | Chief Tech/Sci/R&D Officer | - | 16/12/21 |
Sonya Ghobrial
IRC | Investor Relations Contact | - | - |
Tamara Rogers
SAM | Sales & Marketing | - | 16/12/21 |
Lisa Paley
PRN | Corporate Officer/Principal | - | - |
Keith Choy
PRN | Corporate Officer/Principal | - | - |
Filippo Lanzi
PRN | Corporate Officer/Principal | - | - |
Mairéad Nayager
HRO | Human Resources Officer | - | 01/03/22 |
Bjarne Tellmann
LAW | General Counsel | 57 | 16/12/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Bryan Supran
BRD | Director/Board Member | - | 18/07/22 |
Dame Cox
BRD | Director/Board Member | 64 | 18/07/22 |
Tracy Clarke
BRD | Director/Board Member | 57 | 18/07/22 |
Vindi Banga
BRD | Director/Board Member | 69 | 18/07/22 |
Deirdre Mahlan
BRD | Director/Board Member | 61 | 18/07/22 |
David Lewis
CHM | Chairman | 59 | 23/05/22 |
David Denton
BRD | Director/Board Member | 59 | 01/03/23 |
Brian McNamara
CEO | Chief Executive Officer | 57 | 22/07/21 |
Director/Board Member | - | 18/07/22 | |
Asmita Dubey
BRD | Director/Board Member | - | 18/07/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 9 132 301 104 | 7 461 224 253 ( 81,70 %) | 0 | 81,70 % |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
GlaxoSmithKline Consumer Pvt Ltd.
GlaxoSmithKline Consumer Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Consumer Pvt Ltd. is an Indian company that develops, manufactures, and distributes vaccines and other pharmaceutical products. The company is based in Patiala, India and was founded in 2014. |
Pharmaceuticals: Major
|
Haleon UK Trading Services Ltd.
Haleon UK Trading Services Ltd. Drugstore ChainsRetail Trade Part of Haleon Uk Holdings (No. 3) Ltd., Haleon UK Trading Services Ltd. is a wholesaler of pharmaceutical goods. The company is based in Weybridge, UK. Founded in 2012. |
Drugstore Chains
|
Haleon UK Capital Plc
Haleon UK Capital Plc Regional BanksFinance Part of Haleon Plc, Haleon UK Capital Plc is a financial intermediation company. Haleon UK Capital Plc is based in Middlesex, UK. The British company was founded in 2021. The CEO is Brian James McNamara. |
Regional Banks
|
GlaxoSmithKline Consumer Healthcare Finance Ltd.
GlaxoSmithKline Consumer Healthcare Finance Ltd. Financial ConglomeratesFinance Founded in 2014, GlaxoSmithKline Consumer Healthcare Finance Ltd. is a British company that provides investment services. Part of GSK Plc, the company is based in Brentford, UK. |
Financial Conglomerates
|
GSK Consumer Healthcare Capital US LLC
GSK Consumer Healthcare Capital US LLC Medical/Nursing ServicesHealth Services Part of Haleon Plc, Haleon US Capital LLC is a company that provides healthcare services. Haleon US Capital LLC is based in Wilmington, DE. |
Medical/Nursing Services
|
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The company is based in Brentford, UK. |
Financial Conglomerates
|
Gsk Consumer Healthcare Capital Nl BV
Gsk Consumer Healthcare Capital Nl BV Pharmaceuticals: OtherHealth Technology Part of Haleon Plc, Haleon Netherlands Capital BV is a British company that manufactures medicinal and botanicals. The company is located in the UK. |
Pharmaceuticals: Other
|
GlaxoSmithKline Consumer Healthcare (Overseas) Ltd.
GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. is a British company that offers Voltarol patches and plasters for effective pain relief. The company is based in Brentford, UK. The text from the 'description' mentions that Voltarol offers different kinds of patches and plasters for pain relief and provides information on common causes of foot and ankle pain. The company was founded in 2014. |
Financial Conglomerates
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+60,25% | 841 Mrd | |
+38,96% | 625 Mrd | |
-4,49% | 360 Mrd | |
+18,30% | 327 Mrd | |
+9,64% | 300 Mrd | |
+15,38% | 242 Mrd | |
+3,64% | 228 Mrd | |
+18,09% | 227 Mrd | |
+12,87% | 174 Mrd |
- Borsa valori
- Azioni
- Azione HLN
- Azione HLN
- Società Haleon plc